5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional ‘serotonin-specific reuptake inhibitors’

Serotonergic drugs and valvular heart disease

(2009) Richard B Rothman et al.   Expert Opinion On Drug Safety

Changes in Antidepressant Metabolism and Dosing Across Pregnancy and Early Postpartum

(2009) Dorothy K. Sit et al.   JOURNAL OF CLINICAL PSYCHIATRY

Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression

(2009) M. Elizabeth Sublette et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation

(2009) Baoman Li et al.   PSYCHOPHARMACOLOGY

Relevant Issues in the Monitoring and the Toxicology of Antidepressants

(2008) Sarah M. R. Wille et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid

(2008) X. Liu et al.   DRUG METABOLISM AND DISPOSITION

Pharmacokinetics of Sertraline Across Pregnancy and Postpartum

(2008) Marlene P. Freeman et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Bioenergetics of cerebral ischemia: A cellular perspective

(2008) Leif Hertz   NEUROPHARMACOLOGY

Therapeutic targets in pulmonary arterial hypertension

(2008) Christopher J. Rhodes et al.   PHARMACOLOGY & THERAPEUTICS

Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation

(2008) Baoman Li et al.   PSYCHOPHARMACOLOGY